Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics
- PMID: 28275072
- PMCID: PMC5405242
- DOI: 10.1128/JCM.00147-17
Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics
Abstract
Because nucleic acid amplification tests (NAATs) do not distinguish Clostridium difficile infection (CDI) and asymptomatic C. difficile carriage, the diagnostic predictive value of NAATs is limited when used in patients with a low probability of CDI. In this issue of the Journal of Clinical Microbiology, Truong et al. (J. Clin. Microbiol., 55:1276-1284, 2017, https://doi.org/10.1128/JCM.02319-16) report significant reductions in hospital-onset CDI and oral vancomycin utilization at their institution following implementation of a novel intervention that leveraged their clinical bioinformatics resources to prevent C. difficile testing of stools from patients without clinically significant diarrhea and in patients with recent laxative use.
Copyright © 2017 American Society for Microbiology.
Comment on
-
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.J Clin Microbiol. 2017 May;55(5):1276-1284. doi: 10.1128/JCM.02319-16. Epub 2017 Mar 1. J Clin Microbiol. 2017. PMID: 28250001 Free PMC article.
References
-
- Emmadi R, Boonyaratanakornkit JB, Selvarangan R, Shyamala V, Zimmer BL, Williams L, Bryant B, Schutzbank T, Schoonmaker MM, Amos Wilson JA, Hall L, Pancholi P, Bernard K. 2011. Molecular methods and platforms for infectious diseases testing: a review of FDA-approved and cleared assays. J Mol Diagn 13:583–604. doi: 10.1016/j.jmoldx.2011.05.011. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
